Marinomed Biotech Aktie

Marinomed Biotech für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2N9MM / ISIN: ATMARINOMED6

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
04.06.2025 09:30:53

EQS-PVR: Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Marinomed Biotech AG
Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution

04.06.2025 / 09:30 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018

 

Wien,  3.6.2025

 

Overview

☒ Notification made after deadline

Caution: In case of violations of major holdings notification rules, please pay attention to Section 137 BörseG 2018 (Suspension of voting rights)

 

1. Issuer: Marinomed Biotech AG

2. Reason for the notification: Acquisition or disposal of voting rights

3. Person subject to notification obligation
Abdulmohsen Al Sheikh

4. Name of shareholder(s): 

5. Date on which the threshold was crossed or reached: 20.1.2025

 

6. Total positions

   
% of voting rights attached to shares (7.A)		 % of voting rights through financial/other instruments (7.B.1 + 7.B.2)  
 
Total of both in % (7.A + 7.B)		  
Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed / reached  
3,94 %		  
0,00 %		  
3,94 %		  
1 778 333
Position of previous notification (if applicable)  
4,60 %		  
0,00 %		  
4,60 %		  

 

 

Details

7. Notified details of the resulting situation:

 

A: Voting rights attached to shares

ISIN Code		 Number of voting rights % of voting rights
Direct
(Sec 130 BörseG 2018)		 Indirect
(Sec 133 BörseG 2018)		 Direct
(Sec 130 BörseG 2018)		 Indirect
(Sec 133 BörseG
2018)
ATMARINOMED6 70 115   3,94 %  
SUBTOTAL A 70 115 3,94 %

 

 

B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018

Type of instrument
Expiration Date
Exercise Period		 Number of voting
rights that may be
acquired if the
instrument is exercised
% of voting rights
         
    SUBTOTAL B.1    

 

 

B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018
Type of instrument Expiration Date Exercise Period Physical /
Cash Settlement		 Number of
voting rights		 % of voting rights
           
      SUBTOTAL B.2    

 

 

8. Information in relation to the person subject to the notification obligation:

☒ Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

☐ Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

 

 

9. In case of proxy voting

Date of general meeting: -

Voting rights after general meeting: - is equivalent to - voting rights.

 

10. Sonstige Kommentare:

-

 

 Wien am  3.6.2025


04.06.2025 CET/CEST

Language: English
Company: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Internet: www.marinomed.com

 
End of News EQS News Service

2150548  04.06.2025 CET/CEST

Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!

Nachrichten zu Marinomed Biotech AGmehr Nachrichten

Analysen zu Marinomed Biotech AGmehr Analysen

19.09.23 Marinomed Biotech kaufen Erste Group Bank
05.04.23 Marinomed Biotech kaufen Erste Group Bank
20.09.22 Marinomed Biotech kaufen Erste Group Bank
05.04.22 Marinomed Biotech kaufen Erste Group Bank
14.09.21 Marinomed Biotech kaufen Erste Group Bank
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Newssuche

GO

Aktien in diesem Artikel

Marinomed Biotech AG 20,90 0,00% Marinomed Biotech AG

Letzte Top-Ranking Nachrichten

03.08.25 Gold, Öl & Co. in KW 31: Die Tops und Flops unter den Rohstoffen
03.08.25 KW 31: So performten die DAX-Aktien in der vergangenen Woche
03.08.25 Bitcoin, Ether & Co. in der vergangenen Woche: Wochenbilanz der Kryptowährungen in KW 31
02.08.25 Juli 2025: Die Tops und Flops unter den Rohstoffen im abgelaufenen Monat
02.08.25 Diese Aktien empfehlen Experten zu kaufen

Börse aktuell - Live Ticker

Asiens Börsen in Grün
Die Aktienmärkte in Fernost präsentieren sich am Dienstag mit moderaten Gewinnen.
Aktien ATX  DAX  EuroStoxx 50  Dow Jones  NASDAQ 100  Nikkei 225  S&P 500 

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen